Cargando…
Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238241/ https://www.ncbi.nlm.nih.gov/pubmed/34194631 http://dx.doi.org/10.18632/oncotarget.28001 |
_version_ | 1783714862357020672 |
---|---|
author | Chui, M. Herman Kjaer, Susanne K. Frederiksen, Kirsten Hannibal, Charlotte G. Wang, Tian-Li Vang, Russell Shih, Ie-Ming |
author_facet | Chui, M. Herman Kjaer, Susanne K. Frederiksen, Kirsten Hannibal, Charlotte G. Wang, Tian-Li Vang, Russell Shih, Ie-Ming |
author_sort | Chui, M. Herman |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8238241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-82382412021-06-29 Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma Chui, M. Herman Kjaer, Susanne K. Frederiksen, Kirsten Hannibal, Charlotte G. Wang, Tian-Li Vang, Russell Shih, Ie-Ming Oncotarget Correction Impact Journals LLC 2021-06-22 /pmc/articles/PMC8238241/ /pubmed/34194631 http://dx.doi.org/10.18632/oncotarget.28001 Text en Copyright: © 2021 Chui et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Chui, M. Herman Kjaer, Susanne K. Frederiksen, Kirsten Hannibal, Charlotte G. Wang, Tian-Li Vang, Russell Shih, Ie-Ming Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title | Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title_full | Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title_fullStr | Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title_full_unstemmed | Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title_short | Correction: BRAF(V600E)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
title_sort | correction: braf(v600e)-mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238241/ https://www.ncbi.nlm.nih.gov/pubmed/34194631 http://dx.doi.org/10.18632/oncotarget.28001 |
work_keys_str_mv | AT chuimherman correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT kjaersusannek correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT frederiksenkirsten correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT hannibalcharlotteg correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT wangtianli correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT vangrussell correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma AT shihieming correctionbrafv600emutatedovarianserousborderlinetumorsareatrelativelylowriskforprogressiontoserouscarcinoma |